These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2991522)
1. Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties. Beauchamp LM; Dolmatch BL; Schaeffer HJ; Collins P; Bauer DJ; Keller PM; Fyfe JA J Med Chem; 1985 Aug; 28(8):982-7. PubMed ID: 2991522 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds. Ashton WT; Meurer LC; Cantone CL; Field AK; Hannah J; Karkas JD; Liou R; Patel GF; Perry HC; Wagner AF J Med Chem; 1988 Dec; 31(12):2304-15. PubMed ID: 2848125 [TBL] [Abstract][Full Text] [Related]
3. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues. Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral activity of novel N-substituted derivatives of acyclovir. Boryski J; Golankiewicz B; De Clercq E J Med Chem; 1988 Jul; 31(7):1351-5. PubMed ID: 2455050 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosine. Ashton WT; Canning LF; Reynolds GF; Tolman RL; Karkas JD; Liou R; Davies ME; DeWitt CM; Perry HC; Field AK J Med Chem; 1985 Jul; 28(7):926-33. PubMed ID: 2989523 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity of certain 4-substituted and 2,4-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines. Saxena NK; Hagenow BM; Genzlinger G; Turk SR; Drach JC; Townsend LB J Med Chem; 1988 Aug; 31(8):1501-6. PubMed ID: 2840500 [TBL] [Abstract][Full Text] [Related]
7. Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains. Gus'kova AA; Skoblov MY; Korovina AN; Yasko MV; Karpenko IL; Kukhanova MK; Andronova VL; Galegov GA; Skoblov YS Chem Biol Drug Des; 2009 Oct; 74(4):382-9. PubMed ID: 19691467 [TBL] [Abstract][Full Text] [Related]
8. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines. Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan. Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of various esters of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine. Martin JC; Tippie MA; McGee DP; Verheyden JP J Pharm Sci; 1987 Feb; 76(2):180-4. PubMed ID: 3033195 [TBL] [Abstract][Full Text] [Related]
11. Activation by thymidine kinase and potent antiherpetic activity of 2'-nor-2'-deoxyguanosine (2'NDG). Ashton WT; Karkas JD; Field AK; Tolman RL Biochem Biophys Res Commun; 1982 Oct; 108(4):1716-21. PubMed ID: 6295389 [No Abstract] [Full Text] [Related]
12. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664 [TBL] [Abstract][Full Text] [Related]
14. Successful kinase bypass with new acyclovir phosphoramidate prodrugs. McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of 3-substituted derivatives of 3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purines, tricyclic analogues of acyclovir and ganciclovir. Boryski J; Golankiewicz B; De Clercq E J Med Chem; 1991 Aug; 34(8):2380-3. PubMed ID: 1652016 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Merta A; Votruba I; Rosenberg I; Otmar M; Hrebabecký H; Bernaerts R; Holý A Antiviral Res; 1990 May; 13(5):209-18. PubMed ID: 2168689 [TBL] [Abstract][Full Text] [Related]
17. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study. Golankiewicz B; Ostrowski T; Goslinski T; Januszczyk P; Zeidler J; Baranowski D; de Clercq E J Med Chem; 2001 Nov; 44(24):4284-7. PubMed ID: 11708929 [TBL] [Abstract][Full Text] [Related]
18. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro. Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898 [TBL] [Abstract][Full Text] [Related]
19. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents. Easmon J; Heinisch G; Holzer W; Rosenwirth B J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir. Goslinski T; Golankiewicz B; De Clercq E; Balzarini J J Med Chem; 2002 Nov; 45(23):5052-7. PubMed ID: 12408716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]